- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 334.46M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $2.31B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.21B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $23.49M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $23.45M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.4B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.27B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.06B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.84B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.79B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.49B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $6.5B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $6.21B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 275.18M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $18.49M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$83.55M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $34.16M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $57.98M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.15B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.15B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $52.61M |
| Net Income | Q1 2025 · Mar 31, 2024 | $3.19M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $105.51M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.05B |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.24B |